SRPT · Company research
Sarepta Therapeutics,, Inc. Common Stock (SRPT): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
20records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| The Technical Signals Behind (SRPT) That Institutions Follow - Stock Traders Daily | The Technical Signals Behind (SRPT) That Institutions Follow Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 19, 2026 | neutral | 0 | 0.6 |
| SRPT Oct 2026 12.500 put (SRPT261023P00012500) Stock Price, News, Quote & History - Yahoo! Finance Canada | SRPT Oct 2026 12.500 put (SRPT261023P00012500) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 18, 2026 | neutral | 0 | 0.6 |
| Capricor Or Sarepta: Two DMD Stocks Enter A High-Stakes Week – Which One Has More Upside? - Stocktwits | Capricor Or Sarepta: Two DMD Stocks Enter A High-Stakes Week – Which One Has More Upside? Stocktwits | View source ↗ | Stocktwits | Oct 17, 2026 | neutral | 0 | 0.6 |
| SRPT Oct 2026 25.500 call (SRPT261016C00025500) Stock Price, News, Quote & History - Yahoo! Finance Canada | SRPT Oct 2026 25.500 call (SRPT261016C00025500) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 16, 2026 | neutral | 0 | 0.6 |
| Sarepta Therapeutics, Inc. (SRPT) Stock Forecasts - Yahoo Finance | Sarepta Therapeutics, Inc. (SRPT) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 15, 2026 | neutral | 0 | 0.6 |
| SRPT Stock Drops 4% As Citi Flags Potentially Stronger Rival In Duchenne Space - Stocktwits | SRPT Stock Drops 4% As Citi Flags Potentially Stronger Rival In Duchenne Space Stocktwits | View source ↗ | Stocktwits | Oct 13, 2026 | neutral | 0 | 0.6 |
| Sarepta Therapeutics, Inc. (SRPT) Stock Price, News, Quote & History - Yahoo! Finance Canada | Sarepta Therapeutics, Inc. (SRPT) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 13, 2026 | neutral | 0 | 0.6 |
| Sarepta Therapeutics, Inc. (SRPT) stock price, news, quote and history - Yahoo Finance Singapore | Sarepta Therapeutics, Inc. (SRPT) stock price, news, quote and history Yahoo Finance Singapore | View source ↗ | Yahoo Finance Singapore | Oct 12, 2026 | neutral | 0 | 0.6 |
| Sarepta Therapeutics, Inc. (SRPT) Stock forecasts - Yahoo Finance UK | Sarepta Therapeutics, Inc. (SRPT) Stock forecasts Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 12, 2026 | neutral | 0 | 0.6 |
| Morgan Stanley Views Sarepta CEO Transition As A ‘Positive’ – So, Why Is It Cautious On SRPT Stock In The Near Term? - Stocktwits | Morgan Stanley Views Sarepta CEO Transition As A ‘Positive’ – So, Why Is It Cautious On SRPT Stock In The Near Term? Stocktwits | View source ↗ | Stocktwits | Oct 10, 2026 | neutral | 0 | 0.6 |
| (SRPT) Risk Channels and Responsive Allocation - Stock Traders Daily | (SRPT) Risk Channels and Responsive Allocation Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 9, 2026 | neutral | 0 | 0.6 |
| Top Research Reports for SpaceX, Dell & KLA Corp. | Zacks Research Daily features analysis of 16 major stocks on October 6, 2026. SpaceX benefits from reusable launch technology and Starlink expansion but faces capital requirements. Dell outperforms due to AI infrastructure demand and broad portfolio strength. KLA gains from AI-driven semiconductor demand and process-control intensity. Additional coverage includes analysis of Lockheed Martin's expanded backlog, Deere's pricing actions offsetting commodity headwinds, and concerns about Sarepta's concentrated DMD focus. | View source ↗ | Zacks Investment Research | Oct 6, 2026 | bullish | 0.222 | 1 |
| 37 new hires received Sarepta stock awards that vest yearly if they stay - Stock Titan | 37 new hires received Sarepta stock awards that vest yearly if they stay Stock Titan | View source ↗ | Stock Titan | Sep 30, 2026 | neutral | 0 | 0.6 |
| SRPT On Track For Best Week In 5 Months Ahead Of Late-2026 Clinical Data — Retail Eyes ‘Monumental Comeback’ - Stocktwits | SRPT On Track For Best Week In 5 Months Ahead Of Late-2026 Clinical Data — Retail Eyes ‘Monumental Comeback’ Stocktwits | View source ↗ | Stocktwits | Aug 27, 2026 | neutral | 0 | 0.6 |
| Sarepta Therapeutics (SRPT) Stock Looks Stretched On Sales Yet Reasonable On Broader Checks - Simply Wall Street | Sarepta Therapeutics (SRPT) Stock Looks Stretched On Sales Yet Reasonable On Broader Checks Simply Wall Street | View source ↗ | Simply Wall Street | Aug 25, 2026 | neutral | 0 | 0.6 |
| Sarepta (SRPT) Stock Looks Fully Valued As Sales Trail Fair Value - Yahoo Finance | Sarepta (SRPT) Stock Looks Fully Valued As Sales Trail Fair Value Yahoo Finance | View source ↗ | Yahoo Finance | Aug 25, 2026 | neutral | 0 | 0.6 |
| Sarepta Therapeutics (SRPT) Stock Rally Hinges On Profit Progress And Revenue Drop - Simply Wall Street | Sarepta Therapeutics (SRPT) Stock Rally Hinges On Profit Progress And Revenue Drop Simply Wall Street | View source ↗ | Simply Wall Street | Aug 6, 2026 | neutral | 0 | 0.6 |
| This Analyst Sees 34% Upside For SRPT Stock — Here's Why They Expect A Sustained Rally Next - Yahoo Finance | This Analyst Sees 34% Upside For SRPT Stock — Here's Why They Expect A Sustained Rally Next Yahoo Finance | View source ↗ | Yahoo Finance | Jul 9, 2026 | neutral | 0 | 0.6 |
| SRPT Stock Climbs After Sarepta Seeks Permanent FDA Nod For Two Duchenne Therapies - Stocktwits | SRPT Stock Climbs After Sarepta Seeks Permanent FDA Nod For Two Duchenne Therapies Stocktwits | View source ↗ | Stocktwits | Jun 30, 2026 | neutral | 0 | 0.6 |
| Assessing Sarepta Therapeutics (SRPT) Valuation After Recent Share Price Weakness - Yahoo Finance | Assessing Sarepta Therapeutics (SRPT) Valuation After Recent Share Price Weakness Yahoo Finance | View source ↗ | Yahoo Finance | May 25, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.